Companies / Q32 Bio Inc. / Activity
Activity — Q32 Bio Inc.
13 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 28, 2026 | Orbimed Advisors LLC Director | Buy | Common Stock | $10.00M | +1.3M +55.48% | 3,502,987 11.77% of shares | high |
| May 28, 2026 | Orbimed Advisors LLC Director | Buy | Common Stock | $5.00M | +625K | 625,000 2.10% of shares | high |
| Feb 25, 2026 | Morrison Jodie Pope CEO | Sell | Common Stock | $44.7K | -10K -10.00% | 89,104 0.30% of shares | low |
| Feb 25, 2026 | Kalowski Lee Executive | Sell | Common Stock | $18.0K | -4K -10.00% | 35,943 0.12% of shares | low |
| Feb 25, 2026 | Violette Shelia M. Executive | Sell | Common Stock | $12.7K | -3K -4.82% | 55,569 0.19% of shares | low |
| Feb 24, 2026 | Violette Shelia M. Executive | Grant | Common Stock | $0 | +38K +67.48% | 93,069 0.31% of shares | low |
| Feb 24, 2026 | Morrison Jodie Pope CEO | Grant | Common Stock | $0 | +132K +148.14% | 221,104 0.74% of shares | low |
| Feb 24, 2026 | Kalowski Lee Executive | Grant | Common Stock | $0 | +53K +148.15% | 89,193 0.30% of shares | low |
| Jun 12, 2026 | Thistle Mary Director | Grant | Stock Option (Right to Buy) | — | +10K | 9,810 0.03% of shares | low |
| Jun 12, 2026 | Laporte Kathleen Director | Grant | Stock Option (Right to Buy) | — | +10K | 9,810 0.03% of shares | low |
| Jan 15, 2026 | Grayzel David S. Director | Grant | Stock Option (Right to Buy) | — | +16K | 16,363 0.05% of shares | low |
| Jan 15, 2026 | Lundberg Sven Ante Director | Grant | Stock Option (Right to Buy) | — | +20K | 20,363 0.07% of shares | low |
| Jan 15, 2026 | Laporte Kathleen Director | Grant | Stock Option (Right to Buy) | — | +23K | 23,272 0.08% of shares | low |